SERA
Sera Prognostics Inc
$
2.480
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.480
Open
2.480
VWAP
2.48
Vol
2.33K
Mkt Cap
94.39M
Low
2.480
Amount
5.78K
EV/EBITDA(TTM)
--
Total Shares
32.65M
EV
54.26M
EV/OCF(TTM)
--
P/S(TTM)
909.92
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
175.00K
+360.53%
-0.200
-0%
105.00K
+337.5%
-0.220
-12%
100.00K
+244.83%
-0.210
-12.5%
Estimates Revision
The market is revising No Change the revenue expectations for Sera Prognostics, Inc. (SERA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 6.90%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+6.90%
In Past 3 Month
2 Analyst Rating
-19.35% Downside
Wall Street analysts forecast SERA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SERA is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
-19.35% Downside
Current: 2.480
Low
2.00
Averages
2.00
High
2.00
-19.35% Downside
Current: 2.480
Low
2.00
Averages
2.00
High
2.00
The End
See All Ratings
No Data
Valuation Metrics
The current forward P/E ratio for Sera Prognostics Inc (SERA.O) is -2.95, compared to its 5-year average forward P/E of -4.51. For a more detailed relative valuation and DCF analysis to assess Sera Prognostics Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-4.51
Current PE
-2.95
Overvalued PE
-1.32
Undervalued PE
-7.71
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-2.31
Current EV/EBITDA
0.25
Overvalued EV/EBITDA
1.51
Undervalued EV/EBITDA
-6.12
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
210.19
Current PS
154.25
Overvalued PS
466.02
Undervalued PS
-45.64
Financials
Annual
Quarterly
FY2025Q2
YoY :
-29.17%
17.00K
Total Revenue
FY2025Q2
YoY :
+0.72%
-9.32M
Operating Profit
FY2025Q2
YoY :
-3.10%
-8.05M
Net Income after Tax
FY2025Q2
YoY :
-36.00%
-0.16
EPS - Diluted
FY2025Q2
YoY :
-3.05%
-5.75M
Free Cash Flow
FY2025Q2
YoY :
-946.91%
-141.18
Gross Profit Margin - %
FY2025Q2
YoY :
+66.30%
-24.95K
FCF Margin - %
FY2025Q2
YoY :
+36.81%
-47.33K
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
55.3K
USD
11
3-6
Months
300.4K
USD
17
6-9
Months
926.3K
USD
16
0-12
Months
504.8K
USD
11
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
1.0M
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
55.3K
USD
11
3-6
Months
300.4K
USD
17
6-9
Months
926.3K
USD
16
0-12
Months
504.8K
USD
11
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
SERA News & Events
Events Timeline
2025-05-08 (ET)
2025-05-08
16:43:28
Sera Prognostics names Lee Anderson as Chief Commercial Officer
2025-03-19 (ET)
2025-03-19
16:14:07
Sera Prognostics appoints Jeff Elliott to Board, two members stepping down
2025-03-19
16:07:59
Sera Prognostics reports Q4 EPS (25c) vs. (25c) last year
Sign Up For More Events
Sign Up For More Events
News
9.5
08-06PRnewswireSERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
9.5
07-29PRnewswireSera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025
2.0
06-30BenzingaWhy Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket
Sign Up For More News
People Also Watch
GASS
StealthGas Inc
6.630
USD
-0.60%
FXNC
First National Corp
21.300
USD
0.00%
SMID
Smith-Midland Corp
37.350
USD
0.00%
SKIN
Beauty Health Co
2.180
USD
+15.34%
OVLY
Oak Valley Bancorp
27.450
USD
0.00%
DC
Dakota Gold Corp
4.095
USD
+0.37%
FINW
Finwise Bancorp
18.090
USD
0.00%
FVCB
FVCBankcorp Inc
12.270
USD
-0.08%
ODV
Osisko Development Corp
2.500
USD
-0.40%
BLRX
BioLine RX Ltd
3.560
USD
0.00%
FAQ
What is Sera Prognostics Inc (SERA) stock price today?
The current price of SERA is 2.48 USD — it has increased 0 % in the last trading day.
What is Sera Prognostics Inc (SERA)'s business?
What is the price predicton of SERA Stock?
What is Sera Prognostics Inc (SERA)'s revenue for the last quarter?
What is Sera Prognostics Inc (SERA)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Sera Prognostics Inc (SERA)'s fundamentals?
How many employees does Sera Prognostics Inc (SERA). have?